Infusion therapy
US7329237B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2005 |
| Grant date | Feb 12, 2008 |
| Priority date | — |
| Expiry date | Mar 10, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M25/1011
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
To provide infusion therapy that can effectively transluminally deliver drugs or the like to a target spot without invading areas other than a diseased area. The infusion therapy is for administering a drug, cells or the like, or inserting a treatment instrument into the target diseased area. A blood vessel area including a bifurcated blood vessel connecting to the diseased area is occluded at the distal and the proximal region thereof to form an occluded area, and the drugs or the like are pumped and supplied to the occluded area, which causes the drugs or the like to flow retrogressively and retentively in the bifurcated blood vessel connecting in the occluded area, and be infused and administered to the diseased area.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.